Caris Life Sciences, Inc. (CAI)

NASDAQ: CAI · Real-Time Price · USD

22.26

-0.88 (-3.80%)

At close: Aug 12, 2026, 4:00 PM EDT

22.50

+0.24 (1.08%)

After-hours: Aug 12, 2026, 4:10 PM EDT

Caris Life Sciences Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Cash & Equivalents	690.92	797.8	65.44	60.01	111.14
Short-Term Investments	102.2	2.3	2.2	65.18	302.43
Cash & Short-Term Investments	793.12	800.09	67.64	125.19	413.57
Cash Growth	9.74%	1082.82%	-45.97%	-69.73%	-
Accounts Receivable	116.89	112.14	88.24	55.3	40.23
Inventory	-	-	39.57	49	46.96
Other Current Assets	24.03	21.94	20.27	13.12	15.29
Total Current Assets	1,058	997.8	215.73	242.61	516.04
Net Property, Plant & Equipment	95.72	63.17	67.82	107.09	138.05
Goodwill	19.34	19.34	19.34	19.34	19.34
Other Long-Term Assets	56.73	45.35	40.84	43.86	43.99
Total Assets	1,230	1,126	343.73	412.9	717.42

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Accounts Payable	85.99	39.21	27.79	26.68	27.27
Accrued Expenses	105.27	87.77	77.54	68.29	56.85
Current Portion of Long-Term Debt	0.18	0.17	60.09	0.17	52.79
Total Current Liabilities	191.44	127.15	165.42	95.14	136.91
Long-Term Debt	392.97	378.82	319.44	166.42	169.57
Other Long-Term Liabilities	53.48	42.39	136.06	171.01	158.88
Total Long-Term Liabilities	446.45	421.21	455.5	337.43	328.46
Total Liabilities	637.89	548.36	620.92	432.57	465.36

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Common Stock	0.28	0.28	0.04	0.04	0.14
Treasury Stock	-	-16.9	-0.33	-0.33	-0.33
Additional Paid-in Capital	3,141	3,142	-26.46	-25.7	-24.97
Accumulated Other Comprehensive Income	-	-	0.21	0.22	1.7
Retained Earnings	-	-	-2,472	-2,119	-1,679
Total Common Shareholders' Equity	3,141	3,125	-2,499	-2,145	-1,702
Minority Interest	-	-	2,222	2,125	1,954
Shareholders' Equity	3,141	3,125	-277.19	-19.67	252.06
Total Liabilities & Equity	1,230	1,126	343.73	412.9	717.42

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Total Debt	393.15	378.99	379.53	166.59	222.36
Net Cash (Debt)	399.96	421.1	-311.89	-41.4	191.21
Net Cash Growth	14.61%	-	-	-	-
Net Cash Per Share	1.38	2.52	-8.79	-1.19	5.73
Book Value	3,141	3,125	-2,499	-2,145	-1,702
Book Value Per Share	10.84	18.69	-70.40	-61.38	-51.01
Tangible Book Value	3,122	3,106	-2,518	-2,164	-1,721
Tangible Book Value Per Share	10.78	18.57	-70.94	-61.94	-51.59

SEC Filings: 10-K · 10-Q